NCT02806362View on ClinicalTrials.gov

Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

August 31, 2018

Conditions
Chronic Hepatitis C Virus
Interventions
DRUG

Ombitasvir/paritaprevir/ritonavir

Tablet

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY